Status:
ACTIVE_NOT_RECRUITING
Multiparametric Characterization of Colorectal Cancers (METRAD)
Lead Sponsor:
University Hospital, Brest
Conditions:
Colo-rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecul...
Detailed Description
Around 20% of patients with colorectal cancer present with synchronous liver metastases at the time of diagnosis. In recent years, there has been increasing interest in the high-throughput extraction ...
Eligibility Criteria
Inclusion
- Patients who have undergone surgery for colorectal cancer.
Exclusion
- Patients under legal protection (guardianship, curatorship, etc.)
- Refusal to participate (expressed opposition)
- Individuals with conditions that could interfere with the study protocol or impact data integrity
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07000474
Start Date
March 1 2025
End Date
December 31 2026
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29200